Concord Drugs Ltd vs Sudeep Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Concord Drugs Ltd is ₹ 77.31 as of 12 Jun 15:30 . The P/E Ratio of Concord Drugs Ltd changed from 15.9 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sudeep Pharma Ltd changed from 0 on March 2022 to 0 on March 2021 . This represents a CAGR of 0.0% over 5 years The Market Cap of Concord Drugs Ltd changed from ₹ 25.36 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Sudeep Pharma Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of 0.0% over 5 years The revenue of Concord Drugs Ltd for the Mar '26 is ₹ 37.9 crore as compare to the Dec '25 revenue of ₹ 16.99 crore. This represent the growth of 123.07% The revenue of Sudeep Pharma Ltd for the Mar '26 is ₹ 188.76 crore as compare to the Dec '25 revenue of ₹ 179.17 crore. This represent the growth of 5.35% The ebitda of Concord Drugs Ltd for the Mar '26 is ₹ 1.5 crore as compare to the Dec '25 ebitda of ₹ 0.94 crore. This represent the growth of 59.57% The ebitda of Sudeep Pharma Ltd for the Mar '26 is ₹ 69.02 crore as compare to the Dec '25 ebitda of ₹ 66.81 crore. This represent the growth of 3.31% The net profit of Concord Drugs Ltd changed from ₹ 0.03 crore to ₹ 0.53 crore over 8 quarters. This represents a CAGR of 320.32% The net profit of Sudeep Pharma Ltd changed from ₹ 17.08 crore to ₹ 48.54 crore over 8 quarters. This represents a CAGR of 68.58% The Dividend Payout of Concord Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sudeep Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

About Sudeep Pharma Ltd

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad.
Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli.
Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'.
Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

FAQs for the comparison of Concord Drugs Ltd and Sudeep Pharma Ltd

Which company has a larger market capitalization, Concord Drugs Ltd or Sudeep Pharma Ltd?

Market cap of Concord Drugs Ltd is 101 Cr while Market cap of Sudeep Pharma Ltd is 8,465 Cr

What are the key factors driving the stock performance of Concord Drugs Ltd and Sudeep Pharma Ltd?

The stock performance of Concord Drugs Ltd and Sudeep Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Drugs Ltd and Sudeep Pharma Ltd?

As of June 14, 2026, the Concord Drugs Ltd stock price is INR ₹77.31. On the other hand, Sudeep Pharma Ltd stock price is INR ₹749.5.

How do dividend payouts of Concord Drugs Ltd and Sudeep Pharma Ltd compare?

To compare the dividend payouts of Concord Drugs Ltd and Sudeep Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.